Surfing The NASH Tsunami Podcast V2 - The MASH Podcast - Surfing the MASH Tsunami Podcast

Drug developers, investors, researchers, and corporate executives… Every week, a global community of Fatty Liver Disease stakeholders comes together to explore the most important challenges in diagnosing, treating, and developing medications for patients with Fatty Liver Diseases.

Latest Episode

S6.14.3 – Louise and Roger React to Empowered SLD Patient Advocates

After the roundtable, Louise Campbell and Roger Green share their reactions to the enthusiastic, empowered advocates who are the Harrison Fellows.

S6.14.3 - Louise and Roger React to Empowered SLD Patient Advocates

S6.12 – A Second US Drug Approval! What Semaglutide’s Success Portends For MASLD Care in the US

August 29, 2025

Four leading US KOLs join Roger Green to discuss how the recent FDA approval of semaglutide in MASH will lead to dramatic changes in MASLD care in the US.

S6.11.3 – Expert: Emily Andaya Asks Why There Is No “L” In the (Multi-Metabolic) CKM Initiative

August 19, 2025

Dr. Emily Andaya joins Louise Campbell and Roger Green to discuss the American Heart Association’s CKM initiative and why she believes it should include “L” for liver.

S6.11.2 – Multi-Metabolic Week Part II: Benefits of the Multi-Metabolic Approach

August 19, 2025

Physicians Who Run Multi-Metabolic Clinics in the US and Spain Join Louise Campbell To Discuss Their Clinics (Part I)

S6.11.1 – Multi-Metabolic Week Part I: Role of MASLD In Multi-Metabolic Clinics

August 19, 2025

Physicians Who Run Multi-Metabolic Clinics in the US and Spain Join Louise Campbell To Discuss Their Clinics (Part I)

S6.11 – Multi-Metabolic Practices Integrate MASLD with Other Non-Communicable Diseases

August 15, 2025

This episode focuses on “multi-metabolic medicine,” including a roundtable whose guests run multi-metabolic practices in the US and Spain and an interview with Dr. Emily Andaya, an advocate for including the liver in the American Heart Associations’s CKM initiative.

Our Library of Episodes

In the rapidly evolving landscape of fatty liver disease, Surfing The MASH Tsunami Podcast emerges as a vital platform uniting the brightest minds and boldest voices shaping the future of patient care. Each week, drug developers, investors, researchers, and corporate leaders converge to tackle the most pressing challenges in diagnosing, treating, and developing therapies for Metabolic dysfunction-Associated SteatoHepatitis (MASH) and related conditions. This isn’t just a podcast—it’s a global think tank driving progress in a field where innovation is urgently needed to combat a silent epidemic affecting millions worldwide.

Global Events & Conferences

From exclusive coverage of flagship events like MASH Tag and the EASL Congress to deep dives into trial data and policy shifts, the podcast serves as a front-row seat to international progress. These episodes don’t just report on conferences—they catalyze action by translating academic findings into actionable strategies, fostering collaboration across borders. Whether it’s dissecting the latest biomarker research or analyzing investment trends, the show ensures stakeholders stay ahead in a competitive, fast-paced industry.

Expert Hosts, Multifaceted Perspectives

Led by hepatology pioneer Dr. Stephen Harrison, whose research has redefined understanding of liver disease, alongside liver wellness advocate Louise Campbell MSc AP., who bridges clinical science with patient-centered care, and Roger Green, M.B.A., a forecasting strategist decoding the complexities of drug commercialization, the podcast offers unparalleled expertise. Together, they dissect breakthroughs, debate regulatory hurdles, and explore the socioeconomic factors influencing patient access to care. Their dynamic discussions blend cutting-edge science, real-world advocacy, and market insights, ensuring listeners gain a 360-degree view of the MASH ecosystem.

Roger Green, M.B.A., Host & Producer

HEP Dynamics LLC, SurfingNASH.com

Owner and Principle of HEP Dynamics, sponsor Surfing the NASH Tsunami, a weekly podcast in which a panel of experts discusses commercial developments and challenges in the global NASH market.

Prof. Dr. Jörn M. Schattenberg

Universitätsmedizin Mainz

Jörn M. Schattenberg, M.D. received his medical degree from the University of Mainz, Germany in 2002 after studying Medicine in Mainz (Germany) and at the Tulane University in New Orleans (US) .

Louise Campbell

Founder and Medical Director, Tawazun Health

Louise has over 35-years experience working in the Healthcare Industry in UK and elsewhere in the world, including Europe, Middle East and Australia.

Sponsoring Opportunities

Why MASH Matters

With MASH poised to become the leading cause of liver transplantation by 2030, the work of this community isn’t just important—it’s critical. By uniting stakeholders who might otherwise operate in silos, Surfing The MASH Tsunami accelerates the translation of science into life-saving therapies.

It empowers researchers to align with industry realities, guides investors toward impactful opportunities, and amplifies patient voices in corporate boardrooms. In a field where collaboration is key, this podcast isn’t just driving the discussion—it’s shaping the future of liver health, one episode at a time. Learn more about our Sponsorship Options.

SurfingMASH.Com is honored to have the following Silver Sponsors

Contact SurfingMASH

Tune In, Join the Movement

For anyone invested in the fight against fatty liver disease—whether you’re developing a drug, advocating for patients, or strategizing market access—Surfing The MASH Tsunami is your essential weekly resource. Here, knowledge meets action, and every conversation brings us closer to turning the tide on this global health crisis.

Contact Us

Name *

First

Last *

Last

Company or Organization *

Profession Profession

Email *

Phone *

Country

How did you hear about Surfing NASH? *

Message *

SurfingNASH.com is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:

* You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

By clicking submit below, you consent to allow SurfingNASH.com to store and process the personal information submitted above to provide you the content requested.

Required

I agree to receive other communications from SurfingMASH.com

Captcha

If you are human, leave this field blank.

This is truly an excellent podcast. Roger Green is joined by Akero Therapeutics' Kitty Yale, Manal Abdelmalek (Duke University), Naim Alkhouri (Arizona Liver Health) and Stephen Harrison from Pinnacle Clinical Research. They go through the FDA's recent webcast and dissect the meaning and directions laid out. Interesting points around histology remaining the surrogate for the evaluation of NASH and how we need to have a better way of quantifying NASH histology

A podcast for the NASH community! So many relevant topics. There are guest speakers almost every week who contribute a new energy to each episode. Keep up the good work coming!

The host and other speakers are engaging to listen to yet not too serious or noting. I find mysweldf learning without trying. Excellent to have this on while working at home or driving while running errands.

We have sorely needed a podcast that allows clinicians and academics to focus own major issues in NASH and NAFLD. Their recent coverage of ILC was timely and incisive. I find myself discussing the episodes with colleagues and Twitter buddies.

Listen Now

Copyright © SurfingMASH.Com 2020—2026

site developed and hosted by